GB201105325D0 - Modified nanog molecule and use in reprogramming - Google Patents

Modified nanog molecule and use in reprogramming

Info

Publication number
GB201105325D0
GB201105325D0 GBGB1105325.3A GB201105325A GB201105325D0 GB 201105325 D0 GB201105325 D0 GB 201105325D0 GB 201105325 A GB201105325 A GB 201105325A GB 201105325 D0 GB201105325 D0 GB 201105325D0
Authority
GB
United Kingdom
Prior art keywords
reprogramming
molecule
modified nanog
nanog
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1105325.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Original Assignee
University of Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham filed Critical University of Nottingham
Priority to GBGB1105325.3A priority Critical patent/GB201105325D0/en
Publication of GB201105325D0 publication Critical patent/GB201105325D0/en
Ceased legal-status Critical Current

Links

GBGB1105325.3A 2011-03-30 2011-03-30 Modified nanog molecule and use in reprogramming Ceased GB201105325D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1105325.3A GB201105325D0 (en) 2011-03-30 2011-03-30 Modified nanog molecule and use in reprogramming

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1105325.3A GB201105325D0 (en) 2011-03-30 2011-03-30 Modified nanog molecule and use in reprogramming

Publications (1)

Publication Number Publication Date
GB201105325D0 true GB201105325D0 (en) 2011-05-11

Family

ID=44067605

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1105325.3A Ceased GB201105325D0 (en) 2011-03-30 2011-03-30 Modified nanog molecule and use in reprogramming

Country Status (1)

Country Link
GB (1) GB201105325D0 (en)

Similar Documents

Publication Publication Date Title
ZA201400525B (en) Rspo binding agents and uses thereof
EP2751270A4 (en) Oligomer-conjugate complexes and their use
EP2748192A4 (en) Novel kif5b-ret fusion molecules and uses thereof
ZA201307302B (en) Cd37-binding molecules and immunoconjugates thereof
EP2695894A4 (en) Modified laminin and use thereof
ZA201400562B (en) Axmi205 variant proteins and methods for their use
GB201120993D0 (en) Novel compounds and their use in therapy
IL229844B (en) Anti-psgl-1-antibodies and uses thereof
HK1191034A1 (en) N-carboxyalkyl-auristatins and use thereof n-
PT2665818T (en) Protein expression in plants
EP2738255A4 (en) Erap1-derived peptide and use thereof
EP2686396A4 (en) Adhesive composition and use thereof
EP2711376A4 (en) Fgfr-fc fusion protein and use thereof
EP2817304A4 (en) Novel compounds and their use in therapy
EP2762129A4 (en) Cosmetic composition and cosmetic
EP2716359A4 (en) Complex and uses thereof
SG11201402139UA (en) High mast2-affinity polypeptides and uses thereof
IL213972A0 (en) An armor and armor element for use there in
EP2907870A4 (en) Reprogramming peptide and use thereof
EP2762149A4 (en) Erythropoietin-derived peptide and use therefor
EP2734543A4 (en) Lactoferrin fragments and use thereof
EP2681559A4 (en) Peptide-lipid constructs and their use in a fc-function assay
EP2693879A4 (en) Migrastatins and uses thereof
HK1198587A1 (en) Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2-
GB2489696B (en) Improvements in tags

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)